Nowadays, humanity faces one of the most serious health crises, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The severity of coronavirus disease 2019 (COVID-19) pandemic is related to the high rate of interhuman transmission of the virus, variability of clinical presentation, and the absence of specific therapeutic methods. COVID-19 can manifest with non-specific symptoms and signs, especially among the elderly. In some cases, the clinical manifestations of hyponatremia may be the first to appear. The pathophysiological mechanisms of hyponatremia among patients with COVID-19 are diverse, including syndrome of inappropriate antidiuretic hormone secretion (SIADH), digestive loss of sodium ions, reduced sodium ion intake or use of diuretic therapy. Hyponatremia may also be considered a negative prognostic factor in patients diagnosed with COVID-19. We need further studies to evaluate the etiology and therapeutic management of hyponatremia in patients with COVID-19.
【저자키워드】 COVID-19, SARS-CoV-2, hyponatremia, SIADH, dyselectrolytemia, 【초록키워드】 coronavirus disease, coronavirus, pandemic, therapy, sodium, severity, Transmission, Symptom, virus, Health, management, therapeutic, Patient, etiology, non-specific, Prognostic factor, in some, clinical manifestation, acute respiratory syndrome, secretion, Variability, syndrome, pathophysiological mechanism, ions, sodium ion, evaluate, reduced, absence, digestive, diagnosed with COVID-19, patients with COVID-19, 【제목키워드】 relationship,